Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 2 - Access Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Access Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Access Consortium Today - Breaking & Trending Today
Kapruvia® approved in Switzerland with additional
Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated...
Source: globenewswire.com
Cara Therapeutics Secures Swiss Regulatory Approval For Chronic Kidney Disease Candidate
The Swiss Agency for Therapeutic Products (Swissmedic) has approved Cara Therapeutics’ (NASDAQ:CARA) lead candidate KORSUVA (difelikefalin) ...
Source: businessinsider.com
Looking for Tech-Savvy Educators in the Philippines
In the Philippines, science and mathematics educators go beyond the basics of social media and digital broadcasting content development to get Filipino students and teachers interested in science and technology.
Source: opengovasia.com
Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka
Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com